Search Results - "Gevorkian, D M"

Intravascular Ultrasound Parameters Associated With Stent Thrombosis After Drug-Eluting Stent Deployment by Okabe, Teruo, MD, Mintz, Gary S., MD, Buch, Ashesh N., MD, Roy, Probal, MD, Hong, Young Joon, MD, Smith, Kimberly A., BS, Torguson, Rebecca, BS, Gevorkian, Natalie, MD, Xue, Zhenyi, MS, Satler, Lowell F., MD, Kent, Kenneth M., MD, Pichard, Augusto D., MD, Weissman, Neil J., MD, Waksman, Ron, MD

“…Drug-eluting stent (DES) thrombosis (ST) can be devastating. The study aim was to evaluate intravascular ultrasound (IVUS) predictors for DES thrombosis by…”
Get full text

Increasing Participation of Women in Early Phase Clinical Trials Approved by the FDA by Pinnow, Ellen, MS, Sharma, Pellavi, MPH, Parekh, Ameeta, PhD, Gevorkian, Natalie, MD, Uhl, Kathleen, MD

“…Background Historically women were excluded from participation in phase 1 clinical trials. The goal of this study was to determine the participation of women…”
Get full text

Dynamic changes in the indices of lipid metabolism in erythrocyte membranes at different times of the development of alloxan diabetes by Gevorkian, D M

“…The changes in the content of phospholipids (PL), cholesterol (cr) and its fractions were studied in the processes of lipid peroxidation. At the different…”
Get more information

Impact of “Off-Label” Utilization of Drug-Eluting Stents on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention by Roy, Probal, MD, Buch, Ashesh N., MBChB, Javaid, Aamir, MD, Okabe, Teruo, MD, Raya, Vikram, MD, Pinto Slottow, Tina L., MD, Steinberg, Daniel H., MD, Smith, Kimberly, BS, Xue, Zhenyi, MS, Gevorkian, Natalie, MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, Suddath, William O., MD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…The utilization of drug-eluting stents (DES) in “real world” practice has deviated from Food and Drug Administration-approved indications. Safety concerns have…”
Get full text

Correlates of Clinical Restenosis Following Intracoronary Implantation of Drug-Eluting Stents by Roy, Probal, MD, Okabe, Teruo, MD, Pinto Slottow, Tina L., MD, Steinberg, Daniel H., MD, Smith, Kimberly, BS, Torguson, Rebecca, BS, Xue, Zhenyi, MS, Gevorkian, Natalie, MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, Suddath, William O., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Despite significant decreases in restenosis and repeated intervention achieved using drug-eluting stents (DESs), the benefit has not been homogenous across all…”
Get full text

Quantitative changes in Cu, Zn-superoxide dismutase and catalase isolated from the liver of alloxan diabetic rats by Simonian, M A, Gevorkian, D M, Mkhitarian, V G

“…The contents of Cu, Zn-superoxide dismutase and catalase isolated and purified from the rat liver at the terminal stages of alloxan diabetes were decreased by…”
Get more information

Phospholipid-glycerides, cross-resistance of erythrocytes, malonic dialdehyde level and alpha-tocopherol levels in the plasma and erythrocytes of rats with alloxan diabetes before and after combined antioxidant therapy by Karagezian, K G, Gevorkian, D M

“…Quantitative and qualitative alterations in content of phospholipids were studied in erythrocytes of rats with alloxan diabetes: rate of lipid peroxidation and…”
Get more information

Disturbances of phospholipid metabolism in erythrocyte membranes of patients with acute ischemic stroke by Karagezian, K G, Danielian, R K, Ovakimian, S S, Gevorkian, E M, Ovsepian, L M, Gevorkian, D M, Oveian, G A, Gevorkian, G A, Sekoian, E S, Manucharian, G G, Karagezian, M K

Get more information

The effect of zinc ions on the lipid peroxidation process in the brain in alloxan diabetes by Gevorkian, D M, Melik-Agaeva, E A, Afrikian, A B

Get more information

Enzymatic mechanisms of antiradical cell protection in extreme states by Mkhitarian, V G, Agadzhanov, M I, Gevorkian, D M, Mikaelian, E M

Get more information